ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012